全文获取类型
收费全文 | 1082篇 |
免费 | 67篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 48篇 |
妇产科学 | 33篇 |
基础医学 | 119篇 |
口腔科学 | 49篇 |
临床医学 | 114篇 |
内科学 | 189篇 |
皮肤病学 | 19篇 |
神经病学 | 88篇 |
特种医学 | 33篇 |
外科学 | 93篇 |
综合类 | 82篇 |
预防医学 | 90篇 |
眼科学 | 16篇 |
药学 | 84篇 |
中国医学 | 32篇 |
肿瘤学 | 73篇 |
出版年
2023年 | 8篇 |
2022年 | 28篇 |
2021年 | 64篇 |
2020年 | 33篇 |
2019年 | 30篇 |
2018年 | 42篇 |
2017年 | 26篇 |
2016年 | 26篇 |
2015年 | 31篇 |
2014年 | 43篇 |
2013年 | 60篇 |
2012年 | 63篇 |
2011年 | 111篇 |
2010年 | 44篇 |
2009年 | 49篇 |
2008年 | 67篇 |
2007年 | 68篇 |
2006年 | 49篇 |
2005年 | 43篇 |
2004年 | 37篇 |
2003年 | 41篇 |
2002年 | 46篇 |
2001年 | 11篇 |
2000年 | 20篇 |
1999年 | 23篇 |
1998年 | 16篇 |
1997年 | 11篇 |
1996年 | 7篇 |
1995年 | 9篇 |
1994年 | 3篇 |
1993年 | 6篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 4篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1974年 | 1篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1968年 | 2篇 |
1933年 | 2篇 |
排序方式: 共有1165条查询结果,搜索用时 15 毫秒
1.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
2.
3.
4.
Gerassimos J Mantzaris Kalliopi Petraki Michael Sfakianakis Emmanuel Archavlis Angeliki Christidou Helen Chadio-Iordanides George Triadaphyllou 《Clinical gastroenterology and hepatology》2003,1(2):122-128
BACKGROUND & AIMS: To compare the efficacy of controlled-release budesonide capsules with that of mesalamine for maintaining remission and improving quality of life (QOL) in patients with steroid-dependent Crohn's disease. METHODS: Fifty-seven patients (25 men; mean age, 32 +/- 10.1 yr) with quiescent steroid-dependent Crohn's ileitis, ileocolitis, or colitis (Crohn's disease activity index <150) entered a prospective, investigator-blind trial. Patients were eligible for treatment with azathioprine but had not consented or had developed side effects. Patients were randomized to receive budesonide 6 mg/day (n = 29) or mesalamine 1 g 3 times/day (n = 28). Follow-up assessments were made every 2 months for up to 1 year or until relapse. At each visit, quality of life (QOL) was assessed using the Inflammatory Bowel Disease Questionnaire (IBDQ). RESULTS: There were no significant differences in baseline clinical characteristics between the study groups. The 1-year relapse rate was significantly lower in the budesonide group than in the mesalamine group (55% vs. 82%; 95% confidence interval, 12.4%-41%; P = 0.045). Patients assigned to budesonide also remained in remission longer (241 +/- 114 days vs. 147 +/- 117 days; 95% confidence interval, 32.7-155.3 days; P = 0.003). Compared with mesalamine, budesonide treatment also was associated with a better QOL throughout the study (mean total IBDQ scores 165 +/- 36 vs. 182 +/- 28, respectively; 95% confidence interval, -0.4 to 34.4, P = 0.0001). This advantage was confirmed in patients' self-assessed QOL scores. CONCLUSIONS: Over a 1-year period, controlled-release budesonide was significantly more effective than mesalamine for maintaining remission and improving the QOL of patients with steroid-dependent Crohn's disease. 相似文献
5.
微血管密度和p16基因表达对判定肾癌生物学行为的意义 总被引:1,自引:0,他引:1
目的 :探讨肿瘤内的微血管密度 (IMD)和 p1 6基因表达与肾细胞癌 (RCC)生物学行为的关系。 方法 :采用免疫组织化学方法 ,对 76例RCC患者的根治性肾切除标本 ,检测第Ⅷ因子相关抗原和 p1 6基因表达 ,分析IMD、p1 6基因表达与RCC分期、分级及预后的相关性。 结果 :IMD随临床分期升高而增加 (P <0 .0 5 ) ,而与分级无明显相关性 (P >0 .0 5 ) ,随访 5年内死亡者IMD明显升高 (P <0 .0 1 ) ;癌旁组织中 p1 6阳性率 (75 .0 % )显著高于RCC组织 (4 8.7% ) ,p1 6阳性表达随临床分期、病理分级升高而降低 (P <0 .0 5 ) ,而与IMD呈负相关性。结论 :IMD是预测RCC恶性行为的一个有用指标 ,IMD和p1 6基因表达可为RCC的疗效和预后判定提供重要的资料。 相似文献
6.
Zhang Deli Chen Shulan 《宁夏医科大学学报》1987,(2)
Sinoatrial node electrogram (SNE) was recorded successfully in recent years, using transvenous electrode catheter. Via SNE and intratrialelectrogram (IEG), one could measure sinoatrial conduction time(SACT) directly, observe sinoatrial node (SN) potential changes in cadiac cycles, diagnose some sinus arrhythmias which couldn't be confirmed by surface ECG. All these could offer accurate evidence for differential diagnosis of sick sinus syndrome (SSS). The authors recommend a modified method for the location of the electrode catheter, by which one can increase success rate of obtaining stable SNE. Using this method, the authors recorded SNE in 10 cases with SSS successfully. 相似文献
7.
Alexandros GERAKIS Angeliki BARBATSI Sophia SARANTI Theodora STROGYLOU Dimitrios VALIS 《Nephrology (Carlton, Vic.)》1998,4(5-6):403-406
SUMMARY: We studied the effect of haemodialysis on the serum levels of tumour markers in 78 patients, 49 men and 29 women with a mean age of 61 ± 2 years, who had been undergoing haemodialysis for 39 ± 10 months. No patient had any clinical evidence of malignancy. Serum values of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), squamous-cell-carcinoma-related antigen (SCC), neuron-specific enolase (NSE), tissue polypeptide antigen (TPA), CA 15-3, CA 19–9, and among males prostate-specific antigen (PSA) were determined before and after dialysis. Postdialysis values, after being corrected for haemoconcentration, were compared with predialysis values. A significant increase of 32% was observed in NSE levels ( P <0.001) and of 21% in CA 15-3 ( P <0.001) after haemodialysis. A lesser, but still statistically significant, increase (8-12%) was observed in SCC, AFP and CEA levels ( P <0.05), while the values of the remaining three markers remained unchanged. In conclusion, an increase in some tumour markers was found in our patients after dialysis, a finding which requires further investigation. 相似文献
8.
9.
10.
Supernumerary marker chromosomes (SMCs) in Turner syndrome are mostly derived from the Y chromosome 总被引:2,自引:0,他引:2
Philippos C. Patsalis Michael I. Hadjimarcou Voula Velissariou Sophia Kitsiou-Tzeli Christina Zera Maria Syrrou Evangelia Lyberatou Aspasia Tsezou Angeliki Galla Nicos Skordis 《Clinical genetics》1997,51(3):184-190
DNA and FISH (fluorescence in situ hybridization) analysis were carried out in 12 patients with stigmata of Turner syndrome to determine whether the Supernumerary M arker C hromosome (SMC) found cytogenetically in each of these patients was derived from the Y chromosome. The presence of a Y chromosome in these patients may predispose them to develop gonadoblastoma. PCR-Southern blot analysis, followed by FISH, was used to detect the presence of Y chromosome material. The S ex determining R egion Y (SRY), T estis S pecific P rotein Y -encoded (TSPY) and Y -chromosome R NA R ecognition M otif (YRRM) genes, which map at Yp11.31, Yp11.1–11.2 and Yp11.2/Yq11.21–11.23, respectively, were selected as markers, because they span the whole Y chromosome, and more importantly, they are considered to be involved in the development of gonadoblastoma. It was shown that in 12 patients, all of whom had an SMC, the SMC of 11 was derived from the Y chromosome. Furthermore, the presence of the SRY, TSPY and YRRM gene sequences was determined and FISH analysis confirmed the Y origin of the SMCs. The methodology described in this report is a rapid, reliable and sensitive approach which may be easily applied to determine the Y origin of an SMC carried in Turner syndrome. The identification of an SMC is important for the clinical management and prognostic counseling of these patients with Turner syndrome. 相似文献